Transgene Biotek Ltd
Transgene Biotek Ltd - 526139 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
01 / The disclosure
What the company shared
Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/10/2026 ,inter alia, to consider and approve To consider and approve the appointment of M/s. Eswara Rao & Co., Chartered Accountants, Firm Registration No. 000816S, as the Statutory Auditors of the Company to fill the casual vacancy caused by the resignation of M/s. Vasavi & Co., Chartered Accountants, subject to the recommendation of the Audit Committee and approval of the members of the Company at a general meeting, in accordance with the applicable provisions of the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015..
A question for your research
Confirm the meeting date and reporting period. A scheduled meeting or trading-window closure does not establish that results have been released.
The evidence
Read the source excerpts
PDF text extraction is queued. The summary above comes from the exchange listing.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- e7e33c3d-021e-41aa-beba-67dc1d9463f3
- First collected
- 3 Oct 2026, 17:18 IST
- PDF extraction
- pending